Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Mature
Primary summary from verified readiness
- Confidence
- 76% · stale
- Computed at
- 2026-08-20T10:53:40.642491+00:00
- Claimed
- 95
- Reported
- 93
- Verified
- 86
- Gap
- +9
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-08-20
Adopt with guardrails
- Why
- Fully FDA-approved with a Phase 3 OS win (13.6 vs 8.3 mo, HR 0.60) and traditional-approval maturity, but the boxed-warning CRS/ICANS profile plus an inpatient step-up regimen is a hard operational guardrail, reinforced by real-world ICANS exceeding trial rates.
- Next
- Track real-world CRS/ICANS management data and community-site uptake post full-approval; model the DLL3xCD3 bispecific pattern as a reference for T-cell engager monitoring requirements
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 9
- Tier 1
- 0
- Tier 2
- 4
- Tier 3
- 5
- Supports
- 4
- Contradicts
- 1
- Context
- 4
- Latest observed
- 2025-11-30
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
- 2026-07-19 Reading moved from mature to mature.